ArticleTrials2024

Design and rationale for a randomized, open-label, parallel clinical trial evaluating major adverse cardiovascular events (pharmacological treatment versus diet control) in patients with high-normal blood pressure: the PRINT-TAHA9 trial.

Armin Attar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.